These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 4057404)
1. Prognostic factors in localized prostatic carcinoma. Pontes JE; Wajsman Z; Huben RP; Wolf RM; Englander LS J Urol; 1985 Dec; 134(6):1137-9. PubMed ID: 4057404 [TBL] [Abstract][Full Text] [Related]
2. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). Epstein JI; Walsh PC; Brendler CB J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719 [TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy for stage B2 prostatic cancer. Middleton RG; Smith JA J Urol; 1982 Apr; 127(4):702-3. PubMed ID: 7069834 [TBL] [Abstract][Full Text] [Related]
4. Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival. Fowler JE; Mills SE J Urol; 1985 Jan; 133(1):49-52. PubMed ID: 3964879 [TBL] [Abstract][Full Text] [Related]
5. Morphometric and clinical studies on 68 consecutive radical prostatectomies. Stamey TA; McNeal JE; Freiha FS; Redwine E J Urol; 1988 Jun; 139(6):1235-41. PubMed ID: 3373594 [TBL] [Abstract][Full Text] [Related]
6. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. Bostwick DG; Qian J; Bergstralh E; Dundore P; Dugan J; Myers RP; Oesterling JE J Urol; 1996 Apr; 155(4):1361-7. PubMed ID: 8632575 [TBL] [Abstract][Full Text] [Related]
7. Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy. Epstein JI; Pizov G; Steinberg GD; Carter HB; Pitcock R; Armas OA; Partin A; Walsh PC J Urol; 1992 Jul; 148(1):87-91. PubMed ID: 1613888 [TBL] [Abstract][Full Text] [Related]
8. Pitfalls in preoperative staging in prostate cancer. Mukamel E; Hanna J; deKernion JB Urology; 1987 Oct; 30(4):318-21. PubMed ID: 3660522 [TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229 [TBL] [Abstract][Full Text] [Related]
10. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma. Mohler JL; Figlesthaler WM; Zhang XZ; Partin AW; Maygarden SJ Cancer; 1994 Dec; 74(11):2996-3001. PubMed ID: 7954263 [TBL] [Abstract][Full Text] [Related]
11. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density. Blackwell KL; Bostwick DG; Myers RP; Zincke H; Oesterling JE J Urol; 1994 Jun; 151(6):1565-70. PubMed ID: 7514689 [TBL] [Abstract][Full Text] [Related]
12. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940 [TBL] [Abstract][Full Text] [Related]
13. [Early results following radical prostatectomy in patients with capsule invasion, seminal vesicle infiltration and micrometastases]. Terhorst B; Friedrichs R Urologe A; 1990 Mar; 29(2):91-5. PubMed ID: 2330669 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Epstein JI; Amin M; Boccon-Gibod L; Egevad L; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R Scand J Urol Nephrol Suppl; 2005 May; (216):34-63. PubMed ID: 16019758 [TBL] [Abstract][Full Text] [Related]
15. Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy. Lange PH; Narayan P Urology; 1983 Feb; 21(2):113-8. PubMed ID: 6823718 [TBL] [Abstract][Full Text] [Related]
16. Pelvic lymph node metastasis from prostatic cancer: influence of tumor grade and stage in 452 consecutive patients. Smith JA; Seaman JP; Gleidman JB; Middleton RG J Urol; 1983 Aug; 130(2):290-2. PubMed ID: 6876275 [TBL] [Abstract][Full Text] [Related]
17. Influence of microinvasion of the capsule and/or micrometastasis of regional lymph nodes on disease free survival after radical prostatectomy. Hering F; Schmid HP; Graber P Ann Urol (Paris); 1994; 28(4):196-201. PubMed ID: 7979209 [TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760 [TBL] [Abstract][Full Text] [Related]
19. Risk of prostate carcinoma death in patients with lymph node metastasis. Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561 [TBL] [Abstract][Full Text] [Related]
20. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]